Kronox Lab Sciences Limited Publishes Audited Financial Results for FY26
Kronox Lab Sciences Limited announced its audited financial results for FY26. Total Revenue from Operations for the year ended March 31, 2026, was ₹11,694.71 Lakh. Profit Before Tax was ₹389.19 Lakh, and Profit for the period was ₹169.29 Lakh. Diluted EPS for the year was ₹0.24.
This is a standard disclosure of audited financial results, which is expected. It does not introduce new information that would significantly impact the company's stock price.
The announcement is a routine publication of financial results and does not contain any significant positive or negative developments.
Kronox Lab Sciences Limited has published its audited financial results for the quarter and financial year ended March 31, 2026. The results were advertised in the Indian Express (English) and Financial Express (Gujarati) newspapers on May 23, 2026, in compliance with Regulation 47 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015.
The company reported a Total Revenue from Operations of ₹11,694.71 Lakh for the year ended March 31, 2026. Profit Before Tax stood at ₹389.19 Lakh, and the Profit for the period was ₹169.29 Lakh. The Earnings Per Share (EPS) for the year was ₹0.24 (Diluted). For the three months ended March 31, 2026, Total Revenue from Operations was ₹483.83 Lakh, with Profit Before Tax at ₹138.30 Lakh and Profit for the period at ₹135.81 Lakh. The EPS for the quarter was ₹0.09 (Diluted).
What to do with a filing like this
Kronox Lab Sciences Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Kronox Lab Sciences Limited. Read the original for the full detail.